Purchase Order 75N95A24P00112

Award Date 8/28/24
Potential Completion Date 8/27/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...
Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...
This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $77,874 purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the firm fixed price contract, Twist Bioscience will provide custom cloned pooled oligo libraries in support of the NIH NIA's biomedical research efforts. The contract runs from July 10, 2023 through August 31, 2023 and represents a small purchase awarded directly to the prime contractor...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Twist Bioscience Corporation. The $21,578.25 contract is for the delivery of oligonucleotide pools needed for a gene expression/MPRA (Massively Parallel Reporter Assay) research project. The contract has no set-aside designation and is scheduled for completion by September 30, 2024. Twist Bioscience is a synthetic biology company...
This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order contract to 10X Genomics, Inc. for the provision of 10X Genomics RNA sequencing kits. The $40,289.50 contract has an ultimate completion date of October 25, 2020. There was no set-aside designation used for this award. The contract was issued under a larger indefinite delivery contract valued at up to $750,000...

This federal contract award, valued at $22,735.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the generation of a saturation mutagenesis complementary DNA (cDNA) library of the PINK1 gene, which is associated with Parkinson's disease research. The contract type is a firm fixed price purchase order, and there is no set-aside designation. In addition to this prime contract, Twist Bioscience has also been awarded federal grant sub-awards and has served as a subcontractor on other federal contracts, leveraging its expertise in synthetic biology to support various government research initiatives, including the development of a rapid COVID-19 diagnostic test.

Generated 8/29/24, 9:25 AM